131 papers
Cardiovascular medicine focuses on the heart and blood vessels, exploring how to prevent, diagnose, and treat conditions that affect our circulation. This vital field ranges from understanding high blood pressure and heart failure to investigating the latest breakthroughs in surgical techniques and lifestyle interventions. Because these discoveries directly impact public health, staying informed about emerging research is more important than ever for both specialists and curious readers.
At Gist.Science, we process every new preprint in this category as it appears on medRxiv, ensuring you have immediate access to the latest findings before they undergo formal peer review. For each study, we provide both a plain-language explanation to clarify the core concepts and a detailed technical summary for those seeking deeper scientific context. Below are the latest papers in cardiovascular medicine, organized to help you navigate the most recent developments shaping the future of heart health.
This paper introduces visionECG, a conditional flow matching framework that leverages large-scale UK Biobank data to reconstruct accurate, patient-specific 3D left ventricular geometries and motion directly from widely accessible ECG signals and demographic information, thereby enabling scalable quantitative cardiac assessment without the need for traditional imaging.
This experimental medicine trial demonstrates that short-term preoperative administration of sodium valproate (15 mg/kg/day for ≤14 days) is well-tolerated and reduces post-cardiac surgery myocardial injury by activating ferroptosis protection pathways, whereas longer treatment durations induce adverse heart failure phenotypes and increased injury.
This study analyzing SEER registry data from 2000 to 2021 reveals that soft-tissue and hematologic primary malignant cardiac tumors exhibit distinct demographic profiles, histological compositions, and first-course treatment patterns, with soft-tissue cases more frequently undergoing surgery and hematologic cases more often receiving chemotherapy, though the latter showed higher unadjusted survival rates among those treated with chemotherapy.
This paper presents an updated, open-access Excel template that integrates the CHARMS checklist with the new PROBAST+AI framework to provide a standardized, automated tool for data extraction and risk of bias assessment in systematic reviews of both traditional and AI-driven clinical prediction models.
This systematic review and meta-analysis suggests that postoperative atrial fibrillation is associated with a significantly higher long-term thromboembolic risk following isolated valve surgery compared to coronary artery bypass grafting, although the finding requires further validation due to the limited number of included studies.
This Google Trends infodemiology study reveals that public search interest in Postural Orthostatic Tachycardia Syndrome (POTS) in the United Kingdom experienced a sharp, sustained increase following the onset of the COVID-19 pandemic, with a notable shift toward diagnostic and self-assessment queries that suggests growing public awareness and self-investigation rather than a direct reflection of disease incidence.
The prospective PRIO-Now study demonstrated that a self-report-based screening strategy effectively identified individuals with a high probability of significant coronary artery calcium, showing strong agreement between predicted and observed prevalence while revealing substantial opportunities for initiating preventive lipid-lowering therapy.
This study demonstrates that the increased cardiovascular disease risk associated with lower educational attainment is predominantly mediated (63–82%) by modifiable cardiometabolic risk factors such as obesity, hypertension, and diabetes, suggesting that targeted management of these conditions could significantly reduce socioeconomic health inequalities.
The paper introduces FOXTAIL, a novel R-peak-anchored event domain that visualizes and quantifies beat-to-beat changes in ECG signal direction to reveal dynamic cardiac organization and state variations that conventional methods often miss, without replacing standard diagnostic ECGs.
This study leverages multi-ancestry genomic data from over 4 million individuals to identify hundreds of novel genetic loci and druggable targets for heart failure and its subtypes, highlighting the critical role of metabolic pathways and supporting the expansion of existing therapies like aldosterone synthase inhibitors and type-II activin receptor antagonists.